← Back to Clinical Trials
Recruiting NCT07373041

NCT07373041 Heart Failure Carer Support Programme: Implementation Testing in the UK.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07373041
Status Recruiting
Phase
Sponsor Queen's University, Belfast
Condition Heart Failure
Study Type INTERVENTIONAL
Enrollment 360 participants
Start Date 2026-05-29
Primary Completion 2027-11-29

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
HEart faiLure carer support Programme (HELP)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 360 participants in total. It began in 2026-05-29 with a primary completion date of 2027-11-29.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Background: Heart failure (HF) is widespread in the United Kingdom (UK). Many of these patients rely on support from family carers who are ill-prepared and supported for this role. These carers often experience poor mental and physical health because of their caring role. HEart faiLure carer support Programme (HELP) is the first intervention in the UK developed with carers of patients with HF to support them with looking after themselves and the patients they care for. Aim: To identify the best way of delivering HELP to all carers across the UK and evaluate its impact on carers and patients. Methods: HF Nurses will deliver HELP across 3 sites in the UK to approximately 180 carers of patients with HF. The carers targeted will be those who require additional support (caring for a patient who has HF symptoms). These carers will be nominated for the project by patients identified by nurses at in- and out-patient HF appointments. These patients (around 180) will also be invited to provide information for the project. HELP includes 6 online educational support sessions (1 hour each) delivered weekly, along with an educational booklet and website that provide additional support and advice. We will evaluate the impact of HELP on outcomes for patients (i.e., hospital admissions, GP visits, and quality of life) and carers (i.e., burden, preparedness, and quality of life). Interviews and logs / questionnaires will be completed by participants and staff, which will help us understand how best to deliver HELP. Information for the project will be collected at baseline, during HELP, immediately post-HELP (6 weeks), and 6 months after finishing HELP. Impact: The findings will allow us to develop a plan for giving HELP to all carers throughout the UK to provide them with the education and support they need.

Eligibility Criteria

Carers Inclusion Criteria 1. Aged 18 years or older 2. Physical and mental ability to operate a digital device, engage comfortably in conversation with peers, and be able to read written materials 3. Caring (regular, unpaid care) for a person with a clinical diagnosis of heart failure (HF) who is receiving standard evidence-based HF therapies and has either HF symptoms or 1 episode of decompensation (symptoms requiring medical attention) in previous 6 months 4. Ability to speak and understand English Exclusion criteria 1. Lacking capacity to give consent 2. Under the age of 18 Patients Inclusion Criteria 1. Aged 18 years or older 2. Physical and mental ability to engage comfortably in conversation and be able to read written materials 3. Clinical diagnosis of HF and receiving standard evidence-based HF therapies and has either HF symptoms or 1 episode of decompensation (symptoms requiring medical attention) in previous 6 months 4. Ability to speak and understand English 5. Receiving regular, unpaid support with managing his / her condition from a loved one or friend (e.g., a relative or spouse) Exclusion criteria 1. Lacking capacity to give consent 2. Under the age of 18 3. Carer refused to participate in HELP

Contact & Investigator

Central Contact

Gareth Thompson, PhD

✉ gareth.thompson@qub.ac.uk

📞 07714198795

Frequently Asked Questions

Who can join the NCT07373041 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Heart Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07373041 currently recruiting?

Yes, NCT07373041 is actively recruiting participants. Contact the research team at gareth.thompson@qub.ac.uk for enrollment information.

Where is the NCT07373041 trial being conducted?

This trial is being conducted at Belfast, United Kingdom, Belfast, United Kingdom, Craigavon, United Kingdom, Glasgow, United Kingdom and 1 additional location.

Who is sponsoring the NCT07373041 clinical trial?

NCT07373041 is sponsored by Queen's University, Belfast. The trial plans to enroll 360 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology